All News

This month, we deliver deep dives into the industry's commercial output and outlook and how drugmakers are faring in their public trust mandate—two areas where respective growth pursuits can often go hand-in-hand.

As conference season ramps up, it's a good time to reflect on the impact advances in pharma have on patients.

Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.

Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”

Amid drug pricing blame game, Congress advancing a range of reform efforts to manage and curb pharmacy benefit manager practices.

This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.

The UK BioIndustry Association and Clarivate detail current economic trends in the UK Biotech Financing Report.

Agency hopes to attract more seasoned expertise in manufacturing; also looking to add field inspectors.

Janssen, Johns Hopkins Dermatology’s Ethnic Skin Fellowship Program partnership focuses on improving clinical care and advancing research for skin-of-color patients.

Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future.

The importance of not over-expanding during development, launch.

Manufacturer to withdraw preterm birth drug, amid latest FDA push.

The rise of DOLs doesn’t mean pharma should upend KOL approach.

Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.

The platform is designed to reduce barriers to care for patients with COVID-19.

In its ninth year, the survey includes the opinions of over 240 US-based patient groups on the performance of the pharmaceutical industry in 2021.

The HBA announced the 2023 Woman of the Year, Honorable Mentor, and STAR recipients.

The FDA tapped the Reagan-Udall Foundation to launch the initiative.

Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.

The International Federation of Pharmaceutical Manufacturers and Associations commissioned Ipsos to perform the research.

Agility and better decisions depend on managing risk and gaining insights from data by prioritizing patient and end-user needs. Companies of all sizes, including GSK, Boehringer-Ingelheim, Sanofi, AstraZeneca, and AbbVie, share best practices.

This is the intelligence company's fifth acquisition.

New regulations may require regulators to explore new payment options.

Life sciences professionals will need to keep up with market demand for biologics and biosimilars.

Deeper focus on patient engagement across the pharma/biotech product lifecycle.

Pharmaceutical Executive presents the 2022 APEX Awards, which is presented by a jury of HCPs for breakthroughs in pharmaceutical and healthcare marketing and communications.

Sharif has over a decade of experience working in the healthcare field.